Shijun Yu

433 total citations
20 papers, 284 citations indexed

About

Shijun Yu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shijun Yu has authored 20 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Shijun Yu's work include RNA modifications and cancer (5 papers), Cancer Mechanisms and Therapy (4 papers) and MicroRNA in disease regulation (4 papers). Shijun Yu is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer Mechanisms and Therapy (4 papers) and MicroRNA in disease regulation (4 papers). Shijun Yu collaborates with scholars based in China and United States. Shijun Yu's co-authors include Yong Gao, Yandong Li, Ming Quan, Ning Dou, Jingde Chen, Li Li, Dong Yang, Xiao-Juan Ye, Qinchuan Li and Bin He and has published in prestigious journals such as Cancer Research, Experimental Cell Research and Molecular Cancer.

In The Last Decade

Shijun Yu

20 papers receiving 284 citations

Peers

Shijun Yu
Carolina Pola United States
Siyu Gu China
Mohammad A. Shatat United States
Tait Huso United States
Ben Sang China
Carolina Pola United States
Shijun Yu
Citations per year, relative to Shijun Yu Shijun Yu (= 1×) peers Carolina Pola

Countries citing papers authored by Shijun Yu

Since Specialization
Citations

This map shows the geographic impact of Shijun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijun Yu more than expected).

Fields of papers citing papers by Shijun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijun Yu. The network helps show where Shijun Yu may publish in the future.

Co-authorship network of co-authors of Shijun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shijun Yu. A scholar is included among the top collaborators of Shijun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijun Yu. Shijun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jiahua, et al.. (2025). The Role of CAF‐derived Vitronectin in Promoting Colorectal Cancer Progression and Immunosuppression. Advanced Science. 12(33). e05769–e05769. 1 indexed citations
2.
Yu, Shijun, et al.. (2024). WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma. Cancer Research. 84(17). 2776–2791. 6 indexed citations
3.
Yu, Shijun, et al.. (2024). A new tandem repeat‐enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression. Cancer Science. 115(6). 1851–1865. 2 indexed citations
4.
Yu, Jiahua, et al.. (2024). SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer. Cancer Gene Therapy. 31(5). 755–765. 6 indexed citations
5.
Chong, Xiaodan, Jingde Chen, Nanxin Zheng, et al.. (2022). PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN. Molecular Cancer. 21(1). 118–118. 28 indexed citations
6.
Yu, Shijun, et al.. (2022). miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation. Cell Death Discovery. 8(1). 297–297. 14 indexed citations
7.
Yu, Shijun, et al.. (2021). Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression. Journal of Experimental & Clinical Cancer Research. 40(1). 54–54. 14 indexed citations
8.
Yu, Shijun, et al.. (2021). A Genome-Scale CRISPR Knock-Out Screen Identifies MicroRNA-5197-5p as a Promising Radiosensitive Biomarker in Colorectal Cancer. Frontiers in Oncology. 11. 696713–696713. 7 indexed citations
9.
Yu, Shijun, et al.. (2021). CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling. Journal of Cell Communication and Signaling. 15(3). 383–392. 12 indexed citations
10.
Li, Li, et al.. (2021). Genome-scale CRISPRa screening identifies MTX1 as a contributor for sorafenib resistance in hepatocellular carcinoma by augmenting autophagy. International Journal of Biological Sciences. 17(12). 3133–3144. 10 indexed citations
11.
Li, Yandong, Shijun Yu, Li Li, et al.. (2020). KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell Death and Disease. 11(4). 299–299. 36 indexed citations
12.
Yu, Shijun, et al.. (2020). CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine‐induced STAT3 activation. Journal of Cellular and Molecular Medicine. 25(2). 1024–1034. 17 indexed citations
13.
Li, Yandong, Shijun Yu, Xiao Wang, et al.. (2019). SRPK1 facilitates tumor cell growth via modulating the small nucleolar RNA expression in gastric cancer. Journal of Cellular Physiology. 234(8). 13582–13591. 19 indexed citations
14.
Yu, Shijun, et al.. (2019). RSRC1 suppresses gastric cancer cell proliferation and migration by regulating PTEN expression. Molecular Medicine Reports. 20(2). 1747–1753. 7 indexed citations
15.
Dou, Ning, et al.. (2018). SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression. Cell Proliferation. 51(5). e12484–e12484. 45 indexed citations
16.
Chen, Jingde, et al.. (2018). FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling. Experimental Cell Research. 374(1). 12–18. 10 indexed citations
17.
Yu, Shijun, Li Li, Qiong Wu, et al.. (2018). PPP2R2D, a regulatory subunit of protein phosphatase�2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation. International Journal of Oncology. 52(6). 2011–2020. 10 indexed citations
18.
Wu, Qiong, Shijun Yu, Jingde Chen, Yandong Li, & Yong Gao. (2017). Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level. IUBMB Life. 70(2). 120–128. 7 indexed citations
19.
Dou, Ning, Shijun Yu, Xiao-Juan Ye, et al.. (2016). Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling. Oncotarget. 7(52). 86161–86173. 23 indexed citations
20.
Luo, Qingyong, et al.. (2012). Existence and implications of hop-17(21)-enes in the lower Cretaceous of the Saihantala Sag, Erlian Basin, China. Petroleum Science. 9(2). 154–160. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026